Efficacy, Tolerability and Cost Effectiveness of Disease-Modifying Antirheumatic Drugs and Biologic Agents in Rheumatoid Arthritis

被引：0
作者：
Michael T. Nurmohamed
Ben A. C. Dijkmans
机构：
[1] VU University Medical Centre,Department of Rheumatology
[2] Jan van Breemen Institute,undefined
[3] Slotervaart Hospital,undefined
来源：
Drugs | 2005年 / 65卷
关键词：
Rheumatoid Arthritis; Methotrexate; Infliximab; Etanercept; Adalimumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Over the last decade, several new drugs have become available for the treatment of patients with rheumatoid arthritis. These agents include the new disease-modifying antirheumatic drug (DMARD) leflunomide and the biologic agents, tumor necrosis factor (TNF)-α antagonists and an interleukin (IL)-1 receptor antagonist.
引用
收藏
页码：661 / 694
页数：33
相关论文
共 454 条
[61]  
Haagsma U(2001)Consensus recommendations for the assessment and treatment of rheumatoid arthritis J Rheumatol 28 1423-81
[62]  
van Riel PLCM(2000)Meta-analysis of treatment termination rates among rheumatoid arthritis patients receiving disease-modifying anti-rheumatic drugs Rheumatology 39 975-3
[63]  
De Jong AJL(1986)Sulphasalazine for rheumatoid arthritis: toxicity in 774 patients monitored for one to 11 years BMJ (Clin Res Ed) 293 420-13
[64]  
Karger T(1988)A controlled trial comparing sulfasalazine, gold sodium thiomalate, and placebo in rheumatoid arthritis Arthritis Rheum 31 702-4
[65]  
Rau R(1990)Tolerability of enteric-coated sulphasalazine in rheumatoid arthritis: results of a cooperating clinics study Br J Rheumatol 29 201-3
[66]  
Mottonen T(2000)Cyclosporin for sulfasalazine-induced aplastic anaemia in a patient with rheumatoid arthritis Rheumatology 39 1431-6
[67]  
Hannonen P(1981)Pregnancy in inflammatory bowel disease: effect of sulfasalazine and corti-costeroids on fetal outcome Gastroenterology 80 72-34
[68]  
Leirisalo-Repo M(1996)Two activities of the immunosuppressive metabolite of leflunomide, A77-1726: inhibition of pyrimidine nucleotide synthesis and protein tyro-sine phosphorylation Biochem Pharmacol 52 527-7
[69]  
Kremer JM(1997)The immunosuppressive metabolite of leflunomide, A77 1726, affects murine T cells through two biochemical mechanisms J Immunol 159 22-91
[70]  
Phelps CT(1998)A Leflunomide inhibits pyrimidine de novo synthesis in mitogen-stimulated T-lymphocytes from healthy humans. J Biol Chem 273 21682-4
234567891011